Niegolona cipa

Niegolona cipa




🔞 KLIKNIJ TUTAJ, ABY UZYSKAĆ WIĘCEJ INFORMACJI 👈🏻👈🏻👈🏻

































Niegolona cipa

Andy Bartlett, Deputy CEO and Director of Services Intellectual Property Office
James Horgan, Merck Sharp & Dohme LLC
Dr Bobby Mukherjee, BAE Systems plc
Dr Alicia Instone, Cleveland Scott York
Frances Wilding, Haseltine Lake Kempner
Noam Shemtov, Queen Mary University of London
Lord Justice Colin Birss, Judge of the Court of Appeal
Penelope Aspinall, Jonathan’s Voice
Start
Thursday 15 September 2022, 08:30 AM
End
Thursday 15 September 2022, 06:00 PM
Address
Queen Elizabeth II Centre, The Conference Centre, Broad Sanctuary, London, SW1P 3EE
Price (ex. VAT)
Early Bird - Member (Member) - £240.00

It’s back – a live in-person CIPA Congress! Although the past two years of online Congress have been very successful they cannot re-create the buzz of an in-person gathering. So we are excited to welcome you back to the Queen Elizabeth II Conference Centre on 15 September 2022 for this year’s CIPA Congress.  We have put together a stimulating programme including high-profile keynote speakers and topical panel discussions in which our members share their expertise. Following Congress we will be holding the CIPA Annual Dinner, which is bookable separately from Congress itself. Guest speaker will be none other than Lord Justice Colin Birss, who will also join the Congress panel on mental wellbeing. We hope you will be able to attend both events, and look forward to seeing you.
*Please ensure you make us aware of any allergies or dietary requirements*
If you would like to sponsor any of our conferences , please check our sponsorship page for more information.
Alasdair has an unrivalled breadth of experience across the IP professions. A science and law graduate, he originally qualified as a barrister in the late 70s before going on to qualify as a patent attorney, a solicitor and a trade mark attorney.
He is returning for a second term as CIPA President, having previously led the Institute in 2010-11.
Alasdair worked to introduce and structure the then new professional regulator, IPReg, travelling the country as Vice-President, President and Immediate Past President to gain consensus across the profession over the implementation of the new regulatory regime.
Since then he has kept an eye on regulation while promoting UK patent attorneys’ litigation skills (including working on CIPA’s first Litigation Skills Course and representing CIPA on the IP and Intellectual Property Enterprise Court User Committees), editing the CIPA Journal, assisting in organising Congress, chairing various CIPA committees, speaking at seminars and generally working to ensure CIPA and the UK patent attorney profession both remain world class.
Andy was recently appointed Deputy CEO and Director of Services of the UK Intellectual Property Office, the Executive Agency of UK Government responsible for the intellectual property system in the UK.
In this role, Andy is responsible for all the IPO’s registered rights functions; patents, trade marks and designs, including the associated tribunal and mediation services. He also has responsibility for Digital, Data and Technology (DDaT) services and for delivering the One IPO Transformation Programme.
He has a wealth of leadership experience in various policy, ambassadorial and operational and programme delivery roles within IPO. Most recently he has been leading the IPO’s Programme to transform the way it delivers services for its customers including the deployment of exponential technologies like AI. He has had a longstanding role in initiatives to improve the international patent system including substantive patent law harmonisation and work-sharing frameworks such as the Patent Prosecution Highway.
He is a passionate advocate of the need to modernise the IP system to ensure it is optimally effective for encouraging innovation and economic growth & for delivering excellent customer service.
He joined the UK Intellectual Property Office as a patent examiner in 1990 after graduating in Physics from the University of Birmingham.
Vicki Salmon is a solicitor and UK and European patent attorney and patent attorney litigator. She began her career with Mewburn Ellis, before moving through city law firms and back to patent attorney practices. She is now a co-founder of Impact Intellectual Property LLP, which started in September 2021.
Her work includes advising clients on all forms of IP protection, from strategy and filing, through clearance, disputes and exploitation.
Vicki is chair of the Education Committee, member of Council and vice chair of the Internal Governance Committee. She is also a member of the Litigation Committee, having chaired it for a while, and a member of the Patents Committee. She is a contributor to the CIPA Guide to the Patents Act. As chair of litigation committee, Vicki worked on the development of the UPC with the other UK and EU professions, which involved many meetings with the IPO and appearances in front of a select committee.
James Horgan is Assistant Managing Counsel at Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. He heads the European Patent Department based in London. He has a degree in chemistry and has practiced extensively in the pharmaceutical, vaccine and biotechnological fields for 25 years supporting research sites in England and Italy. He has wide experience of prosecuting applications before the EPO where he appears in ex parte and inter partes Oral Proceedings. He has filed and prosecuted a large number of SPCs. He has been involved in major multi-jurisdictional litigation in cases relating to Vioxx, Fosamax, Cosopt, Propecia, Rebetol, Isentress, Inegy and Janumet with major successes before the Dutch, Irish and Malaysian Supreme Courts in cases relating to second medical use claims, the standards for preliminary injunctions and the judicial assessment of subclaims, as well as before the CJEU and EFTA courts in cases relating to parallel imports and negative term SPCs. He has two ongoing CJEU cases which relate to the interplay of Artr 3(a) and (c) of the SPC Regulation.
He is involved in IP policy issues via the IP Federation, where he was President in 2017-18, EFPIA, IFPMA and Business Europe. He has been included in the IAM list of the World’s 300 Leading IP Strategists employed in industry since its inception in 2015, and is also one of Managing Intellectual Property’s Corporate IP Stars.
Belinda is Senior IP Law Counsel at IBM where she heads up the IP Law teams in Europe, Middle East and Africa (EMEA) and Asia-Pacific (AP), which together provide all aspects of IP Law support for IBM in all geographies outside the Americas. Belinda is a Chartered and European Patent Attorney with a background in Physics and has wide practical experience in drafting, filing and prosecuting patent applications as well as in IP strategy, patent management and copyright issues. Before joining IBM in 2004, Belinda worked in private practice in London.
Belinda is also actively involved in UK and European IP policy matters and is a former President, and a Council member of, the IP Federation, and has been named for several years running by Managing IP as one of its “Corporate IP Stars”.
Dr Bobby Mukherjee is a qualified UK and European patent attorney with over 26 years’ experience of IP gained in private practice and at BAE Systems plc. He is currently the Head of IP (2009 -) at BAE Systems (a FTSE 30 company), which has one of the largest in-house IP teams in the UK. Bobby was elected President of the IP Federation in July 2012 (two year term). During his Presidential term, Bobby played a prominent role, on behalf of Industry, in actively engaging with the Parliamentary stages of the UK IP Bill 2013-2014. This resulted in the UK IP Act 2014, with a positive outcome for Industry.  Until recently, he was an elected member on the Chartered Institute of Patent Attorneys (CIPA) Council. He currently sits on the IP Federation Council, and Confederation of British Industry Trade Group.
Bobby’s career has mostly been spent in the physics field, obtaining and defending patent protection for new products, processes and services globally. He gained a first degree in Natural Sciences (specialising in Physics) from Cambridge University in 1990, and then a Doctorate Degree (D.Phil.) on High Temperature Superconductors from Oxford University in 1995. He has published various research papers in leading Scientific Journals during that time, and during his work experience at the National Physical Laboratory.
Bobby has been named a Corporate IP Star by Managing Intellectual Property every year since 2015.
He received the Legal 500 UK individual of the Year 2019 award for IP.
In his spare time, Bobby enjoys spending time with friends and family, travelling, and closely following cricket.
Rachel joined D Young & Co in 2012 with a general chemical background from a first class Chemistry degree at the University of Oxford. Her portfolio covers a wide range of chemical subject-matter including fuel additives, petroleum and natural gas exploration, antibiotics, pharmaceuticals, polymers, pigments, dyes, food technology, semiconductors, medical devices and nanotechnology. Rachel’s day-to-day work includes drafting patent applications, coordinating multi-territory prosecution, handling EPO opposition and appeal cases, as well as preparing freedom-to-operate opinions for pharma generics or innovators. She has experience arguing before the EPO Opposition Divisions and Appeal Boards and has been involved in several important cases in the areas of fuel additives, food technology and pharmaceuticals.
Rachel has received numerous accolades throughout her career, including the Gibbs prize for final exam results from the University of Oxford, the GlaxoSmithKline prize for patents from Queen Mary University of London and CIPA’s Ballantyne prize for top marks in UK finals. Rachel is a key member of D Young & Co’s Unitary Patent and Unified Patent Court team and has a keen interest in the developments of this new system. Rachel has been recommended for her services by Legal 500 and ranked as a “notable practitioner” by IPSTARS (Managing IP).
Professor David Musker is a Chartered and European Patent Attorney holding a Higher Courts Litigation Certificate and an LLM in Intellectual Property Litigation. He is the author of, amongst other things;
Alicia graduated from the University of Leeds with an honours degree in Colour and Polymer Chemistry and was awarded a PhD in Synthetic Organic Chemistry for her research in the area of photochromics.
Currently, Alicia works particularly in the fields of chemistry, dyes and pigments photochromic materials, medical devices, laboratory consumables, traffic control, oil & gas and natural sciences in general.
Alicia is a Chartered Patent Attorney, a European Patent Attorney and a Chartered UK Trade Mark Attorney, having won the Payne/Bennett Memorial Award for scoring the highest mark in the UK for one of her Final Trade Mark examination papers.
Alongside sitting on the Council for the Chartered Institute of Patent Attorneys’ as President and being an active member of their Trade Marks and Design & Copyright Committees, Alicia also sits on the Council of FICPI-UK as treasurer.
Stephen Rowan joined the EPO in January 2019 as Vice-President for DG1 – Patent Granting Process. He is responsible for the entire Patent Granting Process, from the receiving of applications up to and including opposition and the grant of the patent. This area also includes Quality and Business and User Services.
Located in The Hague, Steve Rowan is Site Manager for the branch of the EPO, which is the largest international organisation in the Netherlands. Before joining the EPO, Stephen Rowan held a number of senior leadership roles in the Intellectual Property Office of the United Kingdom. These included the position of Director of Registered Rights, responsible for the end to end processing of patent, trade mark and design applications and the associated tribunal functions.
Stephen Rowan joined the UK IPO in March 1991 and, in addition to his operational roles, sat as a Principal Hearing Officer and worked on a range of policy issues covering industrial property and copyright. He was Head of the UK Delegation to the Beijing and Marrakesh Diplomatic Conferences and was seconded to the Prime Minister’s Strategy Unit (2004) and HM Treasury (2006) – working on the Gowers Review of IP.
Anita Shaw, IP Law Counsel, is a dual qualified European and UK Patent Attorney at IBM, having first trained in general sciences and then Computer Science. She has wide-ranging experience in protecting and harvesting IP, monetising IP through deals, collaborations and licensing and supports IBM’s open technology efforts. She is also actively involved in policy work in the Data, AI and Copyright fields across the EU and UK.
Anita is involved in a number of external organisations in Europe and the UK for policy, give-back and diversity issues: EPI: Examiner for European Qualifying Examinations, Chartered Institute of Patent Attorneys (CIPA), IP Federation and IP Inclusive (founding member of IP&ME, a diversity network for BAME employees and their allies).
Stephen Rowan joined the EPO in January 2019 as Vice-President for DG1 – Patent Granting Process. He is responsible for the entire Patent Granting Process, from the receiving of applications up to and including opposition and the grant of the patent. This area also includes Quality and Business and User Services.
Located in The Hague, Steve Rowan is Site Manager for the branch of the EPO, which is the largest international organisation in the Netherlands. Before joining the EPO, Stephen Rowan held a number of senior leadership roles in the Intellectual Property Office of the United Kingdom. These included the position of Director of Registered Rights, responsible for the end to end processing of patent, trade mark and design applications and the associated tribunal functions.
Stephen Rowan joined the UK IPO in March 1991 and, in addition to his operational roles, sat as a Principal Hearing Officer and worked on a range of policy issues covering industrial property and copyright. He was Head of the UK Delegation to the Beijing and Marrakesh Diplomatic Conferences and was seconded to the Prime Minister’s Strategy Unit (2004) and HM Treasury (2006) – working on the Gowers Review of IP.
Partner and AI Team Lead at Haseltine Lake Kempner
Frances started her career as a Patent Examiner at the EPO in Munich, returning after 8 years to the UK, where she qualified as a UK and European patent attorney and has worked in private practice ever since, and as a partner at Haseltine Lake (now Haseltine Lake Kempner) since 2005.
At Haseltine Lake Kempner, Frances has worked across a broad variety of fields, and her practice has increasingly moved to simulation systems, algorithms, data centres and the cloud, design and application of neural networks, bioinformatics, and business and internet-based inventions. Frances is active In writing articles around patents and AI and regularly appears in seminars to explain and promote patenting AI.
Professor Noam Shemtov joined CCLS in September 2009 as a lecturer in Intellectual Property and technology Law. He is currently a Professor of Intellectual Property and Technology Law and Deputy Head of CCLS. He lectures in areas of intellectual property, creative industries and technology and his research interests are also focused in these fields.
Noam has led research projects and studies funded by UK Research Councils and by industry, national, supranational and commercial organizations, such as CreativeWorks London, CISAC, Microsoft, WIPO, European Patent Office, Foreign and Commonwealth Office (FCO), UK’s Department for International Development (DFID) and the European Space Agency.
Noam also holds visiting appointments by Dutch, French and Spanish universities, where he lectures regularly in areas pertaining to intellectual property, creative industries and technology. He is a qualified solicitor both in the UK and in Israel.
Drawing on over a decade of experience, Ian advises pharmaceutical and industrial chemistry companies, as well as those in the biotechnology and medical devices sectors, on how to protect their innovation and leverage the value of their intellectual property.
Working with a wide range of clients, Ian guides start-ups through the fundamentals of IP, helping them understand how IP can support their business. He assists spinouts and SMEs to establish and develop their IP portfolios, and delivers clear and actionable recommendations to multinational corporations. Ian’s commercial advice is supported by a wealth of experience in patent drafting and global prosecution, including the UK, Europe, the US and East Asia, as well as contentious matters at the European Patent Office and extensive due diligence expertise.
Ian works across the full patent lifecycle, specializing in new chemical entities (NCEs) for the pharmaceutical sector, particularly those derived using artificial intelligence, and drug repurposing and repositioning. He also coordinates Supplementary Protection Certificates across Europe, and Patent Term Extension worldwide, for marketable pharmaceuticals. As such, he often advises on the issue of plausibility, and collaborates with his clients to ensure that their patent applications are supported by suitable data.
James St.Ville QC is very experienced across patents, trademarks, copyright, designs, confidential information and parallel imports as well as IT, internet, database and software disputes.
Chambers UK has described him as “well regarded for his attention to detail and commerciality”, “extremely intelligent, thoughtful, thorough, careful, very good on his feet and a real pleasure to work with.” “His preparation on every case is superb and detailed, and he has first-class drafting”.
Before taking silk he was consistently recommended as a Leading Junior in Intellectual Property by Chambers UK and Information Technology by the Legal 500 and is a chartered engineer with substantial commercial experience of electronics, optical communications and engineering. His patent work includes electronics, mechanical and medical devices, agrochemicals, pharmaceuticals and engineering disputes. Before becoming a barrister he was leader of the Optical Communications Networks Team at GEC-Marconi Research.
James is an author of Russell-Clarke and Howe on Industrial Designs (10th Edition, 2022) with Martin Howe QC and Ashton Chantrielle. He has been instructed in the High Court, Patents Court, Technology and Construction Court, Court of Appeal, Intellectual Property Enterprise Court (IPEC), UK IPO, EU IPO (formerly OHIM), EPO, EU General Court and the High Court in Northern Ireland.
Sarah Rodriguez is qualified as a patent attorney in the United States, the United Kingdom, and in Europe. She works mainly on patent prosecution in electrical fields including circuit design, nanotechnology, semiconductor devices, medical devices, software applications, signal processing, mechanical structures, optical devices, and communications.
Greg Corcoran is a UK & European patent attorney and solicitor. Since 2007 he has worked in-house at ASML in the Netherlands, on its global patent portfolio and strategy supporting its products that enable manufacture of silicon chips. His practice has involved all aspects of the invention and patent lifecycle from invention collection and risk assessment from before the start of product development, through product development until market release, and support for contentious matters of existing, established products. He is a member of CIPA’s Congress Committee.
Sir Colin Birss was called to the Bar in 1990 and practised in intellectual property law. He was Stand
Biseksualny trojkat
Matka kolegi zrobiła super loda
Masakryczne wytryski

Report Page